- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Unveiling the AI Equity Gap: A Wake-Up Call for Health Care Systems
On this episode of Managed Care Cast, an expert from the University of Minnesota discusses the lack of consideration academic medical centers have for equity when developing governance for AI technologies.
On this episode of Managed Care Cast, we're talking with Paige Nong, PhD, an assistant professor of health policy and management at the University of Minnesota School of Public Health.
Nong was the author of a study published in the Health IT bonus issue titled "Equity and AI Governance at Academic Medical Centers." Her study found that academic medical centers show minimal consideration for equity when developing governance for AI technologies; this highlights the need for health systems and policymakers to prioritize equity literacy and oversight policies.
Listen above or on one of these podcast services:
Digital Health Implementation Among Older Adults: Health Technology Navigators’ Perspectives
May 14th 2025Health technology navigators share perspectives on barriers to and facilitators of digital health access for older, linguistically diverse patients in a Los Angeles safety-net system.
Read More
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Trump Administration Walks Back Mental Health Parity in Insurance Coverage
May 13th 2025The Trump administration has decided to further debate the federal rule passed during the Biden administration that guaranteed insurance coverage for treatment of mental illness and substance abuse.
Read More
For Patients Who Cannot Wait, This Off-the-Shelf CAR NK Treatment for AML Leaves Healthy Cells Alone
May 12th 2025First part of a 2-part interview with Stephen Strickland, MD, MSCI, director of leukemia research for Sarah Cannon Research Institute. Strickland recently presented data from a phase 1 trial of SENTI-202, an investigational chimeric antigen receptor (CAR) natural killer (NK) cell therapy.
Read More
